Shares in Intelligent Ultrasound (MED) have skyrocketed over 150%, at one point reaching up to 180% of this morning’s opening share price, following a new deal with “one of the world's leading ultrasound equipment manufacturers.”
The agreement for Intelligent Ultrasound’s AI software marks the company’s first long-term licence and co-development deal.
At the center of the deal is the integration if Intelligent Ultrasound’s real-time image analysis software onto a range of specialized ultrasound systems. The AIM-listed company develops software to boost scanning quality in medical ultrasound specialties, such anaesthesiology, radiology and primary care medicine.
Work on co-development with the OEM partner has already begun with initial royalty per unit revenues expected in 2021 following regulatory approval.
CEO Stuart Gall commented, “This is a milestone agreement for the Group and we are delighted to have signed our first long-term agreement with one of the world's leading ultrasound companies.
We believe that ScanNav is one of the world's first AI software products to provide real-time image analysis and guidance to sonographers during an ultrasound scan. We expect this to be the first of many agreements for our range of AI based image analysis software."
For more news and updates on Intelligent Ultrasound: